Adjuvant Intraperitoneal 5-Fluorouracil in High-Risk Colon Cancer: A Multicenter Phase III Trial

OBJECTIVE: To evaluate the results of a prospective multicenter randomized study of adjuvant intraperitoneal 5-fluorouracil (5-FU) administered during 6 days shortly after resection of stages II and III colon cancers. SUMMARY BACKGROUND DATA: Systemic adjuvant chemotherapy improves the survival of p...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vaillant, Jean-Christophe, Nordlinger, Bernard, Deuffic, Sylvie, Arnaud, Jean-Pierre, Pelissier, Edouard, Favre, Jean-Pierre, Jaeck, Daniel, Fourtanier, Gilles, Grandjean, Jean-Paul, Marre, Philippe, Letoublon, Christian
Format: Artigo
Jezik:Inglês
Izdano: 2000
Teme:
This Month's Feature
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1421018/
https://ncbi.nlm.nih.gov/pubmed/10749603
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items